Publication | Closed Access

Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: A phase II trial

Surgical OncologyUrologyRadiation TherapyMedicineRadical ProstatectomyProstatic DiseaseOncologyRadiation OncologyHigh Risk